Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2026-03-06 @ 9:39 PM
Study NCT ID:
NCT01806961
Status:
TERMINATED
Last Update Posted:
2016-08-03
First Post:
2013-03-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.
Sponsor:
Spirig Pharma Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-06
First Submit QC Date:
None
Study First Post Date:
2013-03-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-14
Results First Submit QC Date:
None
Results First Post Date:
2016-01-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-21
Last Update Post Date:
2016-08-03
Last Update Post Date Type:
ESTIMATED